Hyperparathyroidism
Co-Pay Relief Program Fund Notices
Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!
Approved and Donation Ready
This fund has been developed in response to patients who have contacted PAF for help with their medication expenses and could not find help. While this fund has been fully designed and we are ready to provide needed support to these patient communities, this fund is not yet able to accept applications for assistance as we are still working to secure charitable donations that will allow us to open it.
If you, or someone you know, would like to contribute to this fund, please visit our Donors page for more information on how to provide critical support for patients in need.
Fund TypeCo-Pay, Co-insurance & Deductible (medications and office visits), Medical Insurance Premiums
Maximum Award Level$2,500 Per Year
- Household Income Requirements 400% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
- Insurance Requirements Medicare, Medicaid, or Military Benefits
- Must reside and receive treatment in the United States.
About Hyperparathyroidism
Hyperparathyroidism occurs when there is an excess of parathyroid hormone (PTH) in the bloodstream due to overactivity of one or more of the body’s four parathyroid glands, the cause is often the result of a benign adenoma forming on a parathyroid gland. The parathyroid hormone helps maintain an appropriate balance of calcium in the bloodstream and in tissues that depend on calcium for proper functioning. Hyperparathyroidism can occur at any age, but is more common in people between age 50 and 60, and women are affected about three times as often as men.
There are two types of hyperparathyroidism, primary and secondary. Primary hyperparathyroidism occurs when one or more of the parathyroid glands are overactive causing an overproduction of the parathyroid hormone, resulting in high levels of calcium in the blood known as hypercalcemia.
Secondary hyperparathyroidism refers to the excessive secretion of parathyroid hormone by the parathyroid glands in response to hypocalcemia and associated hyperplasia of the glands, in an attempt to keep the calcium levels normal. This disorder is especially seen in patients with chronic kidney failure and vitamin D deficiency.
At younger ages, Primary hyperparathyroidism is often caused by a familial hyperparathyroidism syndrome, which usually causes several of the parathyroid glands to enlarge rather than a single gland to become enlarged.
- CancerCare866-55-COPAY
- Good Days877-968-7233
- Healthwell Foundation800-675-8416
- National Organization for Rare Disorders800-999-6673
- Needy Meds800-503-6897
- Patient Access Network Foundation866-316-7263
- Patient Services Inc.800-366-7741
- The Assistance Fund855-845-3663
